[Drug therapy of ventricular arrhythmias - a contemporary perspective].
Grönefeld
G C
GC
Johann Wolfgang Goethe-Universität, Medizinische Klinik IV, Frankfurt am Main, Germany. hohnloser@em.uni-frankfurt.de
Hohnloser
S H
SH
D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000628:therapy*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy / Q000401:mortality; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004311:Double-Blind Method; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy / Q000401:mortality; D006352:Heart Ventricles; D006801:Humans; D006827:Hydantoins; D007093:Imidazoles / Q000627:therapeutic use; D048289:Imidazolidines; D015201:Meta-Analysis as Topic; D010879:Piperazines / Q000627:therapeutic use; D010919:Placebos; D011322:Primary Prevention; D011446:Prospective Studies; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D006827:Hydantoins; D007093:Imidazoles; D048289:Imidazolidines; D010879:Piperazines; D010919:Placebos; C086123:azimilide; D000638:Amiodarone